クッション から 罪人 へ: 心臓 の 脂肪 組織 が 心血管 疾患 に 果たす 役割
Shaun Khanna1, Gurkeerat Mann2, Sheran Vasanthakumar3
1Cardiovascular Program, The George Institute for Global Health, Sydney, NSW, Australia; Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia; Baker Heart and Diabetes Institute, Melbourne, Vic, Australia.
Heart, lung & circulation
|September 4, 2025
まとめ
心臓の周りの脂肪層である心臓の脂肪組織 (Epicardial adipose tissue,EAT) は,心臓血管疾患とますます関連しています. EATを理解する
科学分野:
- 心臓病科
- 代謝に関する研究
- 医療用イメージング
背景:
- エピカルディア脂肪組織 (EAT) は,心臓を囲む内臓脂肪である.
- EATは心臓血管疾患の病原性において重要な役割を果たします.
- その生物活性化合物は冠動脈疾患,心不全,心律動乱に影響します.
研究 の 目的:
- 心臓の脂肪組織に関する現在の理解をレビューする.
- EATの生理学,測定,病理学,治療の可能性をカバーする.
主な方法:
- EATに関する現代の研究の文献レビュー.
- EATの評価のための心臓のコンピュータトモグラフィーにフォーカスします.
- 心血管疾患の発達におけるEATの役割の分析
主要な成果:
- EATは冠動脈疾患,心不全,心律動乱に 関わっている.
- 心臓のコンピュータートモグラフィーは,体積と密度の EAT 測定に最適です.
- EATはライフスタイル,薬学,外科的介入の変更可能なターゲットです.
結論:
- 心臓の脂肪組織は心臓血管の健康に 重要な役割を果たします
- 心臓CTによるEATの正確な評価は,そのダイナミックな性質を理解するのに役立ちます.
- EATをターゲットにすることで 心血管疾患に対する有望な治療戦略が生まれます
関連する概念動画
Hypodermis
5.3K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
5.3K
Cholesterol: Significance and Regulation
669
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
669
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Atherosclerosis I: Introduction
74
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
74


